EPW
CL icon

Evolve Private Wealth’s Colgate-Palmolive CL Stock Holding History

Evolve Private Wealth’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Sell
2,489
-5,168
-67% -$452K 0.01% 875
2026
Q1 		$653K Buy
7,657
+189
+3% +$16.8K 0.03% 461
2025
Q4 		$590K Buy
+7,468
New +$586K 0.04% 467

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Evolve Private Wealth's CL Position: Q2 2026 in Review

Evolve Private Wealth reduced its Colgate-Palmolive (CL) stake by 67% in Q2 2026, selling an estimated $452K and leaving 2,489 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #875.

Evolve Private Wealth first reported a position in CL in Q4 2025 and has held it in 3 quarters since. The position peaked at $653K in Q1 2026. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Evolve Private Wealth held 2,489 shares of Colgate-Palmolive worth $228K as of Q2 2026.
  • Evolve Private Wealth sold 5,168 Colgate-Palmolive shares in Q2 2026, an estimated $452K.
  • Colgate-Palmolive made up 0.01% of Evolve Private Wealth's portfolio in Q2 2026, its #875 holding.
  • Evolve Private Wealth first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Colgate-Palmolive position peaked at $653K in Q1 2026.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.